Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

NCT01939977 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Secondary Hyperparathyroidism Due to Renal Causes

Interventions

DRUG: Paricalcitol
DRUG: Calcifediol

Sponsor

Fundación Senefro

Collaborators

[object Object]
[object Object]